Carregant...
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response()
Over the last decade we have witnessed the convergence of two powerful experimental designs toward a common goal of defining the molecular subtypes that underpin the likelihood of a cancer patient responding to treatment in the clinic. The first of these ‘experiments’ has been the systematic sequenc...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4003351/ https://ncbi.nlm.nih.gov/pubmed/24607840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gde.2013.12.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|